These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets. Sato R; Semba T; Saya H; Arima Y Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010 [TBL] [Abstract][Full Text] [Related]
23. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ. Tan EJ; Olsson AK; Moustakas A Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613 [TBL] [Abstract][Full Text] [Related]
24. Extracellular Vesicles: A New Perspective in Tumor Therapy. Sun YZ; Ruan JS; Jiang ZS; Wang L; Wang SM Biomed Res Int; 2018; 2018():2687954. PubMed ID: 29850495 [TBL] [Abstract][Full Text] [Related]
25. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity. Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213 [TBL] [Abstract][Full Text] [Related]
26. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis. Garg M Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181 [TBL] [Abstract][Full Text] [Related]
27. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. van der Horst G; Bos L; van der Pluijm G Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124 [TBL] [Abstract][Full Text] [Related]
28. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis. Neelakantan D; Drasin DJ; Ford HL Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627 [TBL] [Abstract][Full Text] [Related]
29. Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon. Tzanakakis G; Kavasi RM; Voudouri K; Berdiaki A; Spyridaki I; Tsatsakis A; Nikitovic D Dev Dyn; 2018 Mar; 247(3):368-381. PubMed ID: 28758355 [TBL] [Abstract][Full Text] [Related]
30. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance. Singh D; Siddique HR Cancer Metastasis Rev; 2024 Mar; 43(1):155-173. PubMed ID: 37775641 [TBL] [Abstract][Full Text] [Related]
31. Inflammation linking EMT and cancer stem cells. Zhou C; Liu J; Tang Y; Liang X Oral Oncol; 2012 Nov; 48(11):1068-75. PubMed ID: 22766510 [TBL] [Abstract][Full Text] [Related]
35. Intra-tumor heterogeneity from a cancer stem cell perspective. Prasetyanti PR; Medema JP Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166 [TBL] [Abstract][Full Text] [Related]
36. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Dongre A; Weinberg RA Nat Rev Mol Cell Biol; 2019 Feb; 20(2):69-84. PubMed ID: 30459476 [TBL] [Abstract][Full Text] [Related]
37. Tumor and its microenvironment: a synergistic interplay. Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661 [TBL] [Abstract][Full Text] [Related]
38. TGFβ and matrix-regulated epithelial to mesenchymal transition. Moustakas A; Heldin P Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266 [TBL] [Abstract][Full Text] [Related]